The 10 latest articles on Pharmaceuticals & Biotech come from 9 sources, published between Nov 9 and Nov 13. Most come from markets.businessinsider.com (2).
Organizations: FDA (4), U.S. Food and Drug Administration (2), NDA (2), Federal Food (2), NeOnc Technologies Holdings, Inc. (2)
Places: US (2), MD (2)
Science News from research organizations Consider farmers at individual level when controlling livestock disease outbreaks Date: July 15, 2022 Source: University of Warwick Summary: Livestock diseases will be better managed by incorporating the behaviors of individual farmers into national infection control policies,…
NEW YORK, Nov 12 - The US Food and Drug Administration has shelved the fast-track drug review initiative launched during the Trump administration by former Commissioner Marty Makary, according to six... Merck & Co., Inc. US FDA shelves commissioner's voucher program for speedy…
9 November 2026 Qureight’s Fibr8 model to provide structural assessment as secondary endpoint in Contineum’s Phase 2 PROPEL-IPF clinical trial examining the safety and efficacy of PIPE-791 in idiopathic pulmonary fibrosis (IPF) patients Announcement comes after a recent European Respiratory Journal viewpoint by Qureight…
From the first day of his life, little infant Adnan has suffered a seizure roughly every 13 minutes. One can only imagine the reactions from his Dubai hospital bedside when, having received a still-experimental drug, his seizures stopped for the day.
News Drug Development With an approval apiece, the verdict is still out on AbbVie’s and BMS’ twin neuro buys November 9, 2026 | 5 min read | Tristan Manalac Twitter LinkedIn Facebook Email Print iStock, Thawatchai Chawong After emraclidine’s schizophrenia fail and Cobenfy’s laggard launch,…
Recent Quotes My Watchlist Indicators Markets Stocks ETFs Tools Markets: Overview News Currencies International Treasuries Genentech’s Divarasib Shows Superiority in Head-to-Head Phase III Trial Against Approved KRAS G12C Inhibitors in Non-Small Cell Lung Cancer By: Genentech via Business Wire July 02, 2026 at…
Nov 13, 2026, 8:49 AM ETRezolute, Inc. (RZLT) StockBy: Jonathan Block, SA News Editorkoto_feja Rezolute (RZLT) said that preliminary data from its phase 3 upLIFT study of ersodetug in tumor hyperinsulinism found that 13 of 16 enrolled patients achieved at least a 50% reduction from baseline in glucose…
News Conference News European Congress on Obesity 2025 App-Based Support Aids Weight Loss With Semaglutide, Studies Show Digital programs incorporating behavioral therapy led to solid reductions in body weight, and did so at lower drug doses. By Michael O'Riordan May 13, 2025 MALAGA,…
TipRanks Nov. 11, 2026, 08:05 AM NeOnc Technologies (NTHI) announced that the FDA has granted the company a Type B End-of-Phase meeting to discuss a potential accelerated approval pathway for intranasal NEO100 in recurrent or progressive IDH-mutant grade 4 astrocytoma. The meeting is scheduled for…
PRESS RELEASE GlobeNewswire Nov. 11, 2026, 08:00 AM CALABASAS, Calif., Nov. 11, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI) (“NeOnc” or the “Company”), a clinical-stage biopharmaceutical company developing therapies for central nervous system (CNS) cancers, today announced that the U.S. Food and…
Pipelines, trials, approvals, safety, manufacturing, and next‑gen therapies.
An article joins this feed when it matches these terms. Each one is also a search of its own.